Intermediate Outcomes of Femoropopliteal Stenting in Women: 3-Year Results of the DURABILITY II Trial

Keyphrases

• Ankle-brachial Index 100%
• Femoropopliteal 100%
• Walking Impairment Questionnaire 100%
• Secondary Patency 66%
• Walking Distance 66%
• 3-year Follow-up 66%
• Female Patients 33%
• With Woman 33%
• Primary Patency 33%
• Clinical Improvement 33%
• Non-randomized Trial 33%
• Index Score 33%
• Endovascular Treatment 33%
• Patency Rate 33%
• Relative Change 33%
• Walking Speed 33%
• Clinical Score 33%
• Popliteal 33%
• Superficial Femoral Artery 33%
• Nitinol Stent 33%
• Stair Climbing 33%
• Speed Climbing 33%

Medicine and Dentistry

• Stenting 100%
• Ankle Brachial Index 100%
• Walking Distance 66%
• Nitinol 33%
• Walking Speed 33%
• Superficial Femoral Artery 33%
• Stair Climbing 33%